Withdrawing drugs: nefazodone, the start of the latest saga.
Edwards
I Ralph
IR
Uppsala Monitoring Centre, S-753 20, Uppsala, Sweden. ralph.edwards@who-umc.org <ralph.edwards@who-umc.org>
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D017277:Drug Approval; D016903:Drug Monitoring; D006801:Humans; D010879:Piperazines; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D014230:Triazoles / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone